IMMUNO-ONCOLOGY
Immunotherapy as frontline treatment for advanced hepatocellular cancer
J. Blokken, Tom Feys
Synergism between CTLA-4 and PD-(L)1 inhibition: the nivolumab-ipilimumab story
J. Blokken, Tom Feys, P. Coulie
Immune Checkpoint Inhibition for metastatic penile cancer: a case report and review of the literature
K. Dewulf, A-S. Van Rompuy, G. De Meerleer, K. Goffin, C. Mai, H. erlinde Dumez, M. Albersen
The emerging role of immunotherapy in small-cell lung cancer
J. Blokken, Tom Feys
Immunotherapy for the treatment of triple-negative breast cancer
J. Blokken, Tom Feys, K. Punie
Immune checkpoint inhibitor therapy and COVID-19: What do we know so far?
T. Rawson, Tom Feys